PREVENTION OF CHRONIC ASTHMA IN YOUNG CHILDREN
预防幼儿慢性哮喘
基本信息
- 批准号:6170421
- 负责人:
- 金额:$ 26.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-09-01 至 2002-08-31
- 项目状态:已结题
- 来源:
- 关键词:airborne allergen antiinflammatory agents asthma case history child behavior clinical research disease /disorder prevention /control health care cost /financing health care service utilization home health care human subject immunoglobulin E infant human (0-1 year) low socioeconomic status maternal behavior middle childhood (6-11) nursing intervention preschool child (1-5) quality of life respiratory infections
项目摘要
DESCRIPTION: The goal of this five year research demonstration and
education project is to determine if an intensive intervention using nurse
home visitors can reduce asthma prevalence among children from low income
households who begin wheezing in infancy. One hundred eighty infants and
their parents who are Medicaid-eligible will be recruited from public health
settings. About half of the children will be from minority families.
Families will be randomly assigned to a nurse home visitor intervention
group or a control group. In the intervention group, nurse home visitors
will work with parents for one year to target allergens in the home, reduce
environmental tobacco smoke, and improve the quality of maternal caregiving,
particularly as it relates to asthma prevention and management. A control
group will receive information related to preventing asthma. Repeated
assessments of the targeted variables will be made in both groups. In
addition, family history of asthma and children's IgE levels at enrollment
will be assessed, since these variables are expected to interact with the
targeted variables to affect outcome. Maternal psychological resources also
will be assessed, as this factor has been associated with responsivity to
home visitor interventions. Respiratory infections and use of
anti-inflammatory medications will be monitored as possible mediating
variables. All children will be followed to 4 years of age. Outcomes to be
measured include asthma status, functional severity of asthma by maternal
report and by cumulative symptom reports, pulmonary functions and IgE
levels, quality of life and child behavioral adjustment, and health care use
and costs.
The principal investigator is Mary Klinnert, Ph.D., who is Chief of
Pediatric Psychology at the National Jewish Center for Immunology and
Respiratory Medicine and Associate Professor of Psychiatry at the University
of Colorado Health Sciences Center. Co-investigators are Lanny Rosenwasser,
M.D., Larry Borish, M.D., and Andy Liu, M.D.
描述:本研究的目标是五年的示范和
教育项目是确定是否使用护士进行强化干预,
家庭访视可以降低低收入儿童的哮喘患病率
在婴儿期开始喘息的家庭。 一百八十个婴儿,
符合医疗补助条件的父母将从公共卫生部门招募
设置. 大约一半的孩子将来自少数民族家庭。
家庭将被随机分配到护士之家访问者干预
组或对照组。 在干预组中,
将与家长合作一年,以针对过敏原在家里,减少
环境烟草烟雾,提高产妇分娩质量,
特别是当其涉及哮喘预防和管理时。 控制
小组将收到有关预防哮喘的信息。 重复
将对两组的目标变量进行评估。 在
此外,哮喘家族史和儿童入组时的IgE水平
将进行评估,因为预计这些变量将与
有针对性的变量来影响结果。 产妇心理资源也
将进行评估,因为这一因素与以下方面的反应有关:
家访干预。 呼吸道感染和使用
将监测抗炎药物,尽可能介导
变量 所有儿童将被随访至4岁。 结果将是
测量包括哮喘状态、母亲哮喘的功能严重程度、
报告和累积症状报告、肺功能和IgE
水平、生活质量和儿童行为调整以及医疗保健使用
和成本。
主要研究者是玛丽克林纳特博士,他是
国家犹太免疫学中心的儿科心理学,
大学呼吸内科和精神病学副教授
科罗拉多健康科学中心。 合作调查者是兰尼·罗森瓦瑟,
医学博士,Larry Borish医学博士Andy Liu,M.D.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mary D. Klinnert其他文献
#69 The relationship between psychological function, immune parameters, and cortisol response to stress in youth at risk for atopy
- DOI:
10.1016/j.bbi.2005.10.075 - 发表时间:
2005-07-01 - 期刊:
- 影响因子:
- 作者:
Kim Kelsay;Tasha N. Aper;Mary D. Klinnert - 通讯作者:
Mary D. Klinnert
Mary D. Klinnert的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mary D. Klinnert', 18)}}的其他基金
Children's Food Allergies: Assessing Family Management and Adaptation
儿童食物过敏:评估家庭管理和适应
- 批准号:
7788497 - 财政年份:2010
- 资助金额:
$ 26.65万 - 项目类别:
Children's Food Allergies: Assessing Family Management and Adaptation
儿童食物过敏:评估家庭管理和适应
- 批准号:
8015216 - 财政年份:2010
- 资助金额:
$ 26.65万 - 项目类别:
EFFECT OF ETS EXPOSURE ON STEROID RESPONSIVENESS AMONG CHILDREN WITH ASTHMA
ETS 暴露对哮喘儿童类固醇反应的影响
- 批准号:
7719401 - 财政年份:2008
- 资助金额:
$ 26.65万 - 项目类别:
EMOTION REGULATION AND CORTISOL IN CHILDREN WITH ATOPY
特应性儿童的情绪调节和皮质醇
- 批准号:
7604340 - 财政年份:2007
- 资助金额:
$ 26.65万 - 项目类别:
EFFECT OF ETS EXPOSURE ON STEROID RESPONSIVENESS AMONG CHILDREN WITH ASTHMA
ETS 暴露对哮喘儿童类固醇反应的影响
- 批准号:
7604361 - 财政年份:2007
- 资助金额:
$ 26.65万 - 项目类别:
EMOTION REGULATION AND CORTISOL IN CHILDREN WITH ATOPY
特应性儿童的情绪调节和皮质醇
- 批准号:
7377740 - 财政年份:2006
- 资助金额:
$ 26.65万 - 项目类别:
EMOTION REGULATION AND CORTISOL IN CHILDREN WITH ATOPY
特应性儿童的情绪调节和皮质醇
- 批准号:
7200502 - 财政年份:2005
- 资助金额:
$ 26.65万 - 项目类别:
相似海外基金
New Antiinflammatory Agents to Prevent Damage to Islets
防止胰岛损伤的新型抗炎剂
- 批准号:
6576060 - 财政年份:2002
- 资助金额:
$ 26.65万 - 项目类别:
New Antiinflammatory Agents to Prevent Damage to Islets
防止胰岛损伤的新型抗炎剂
- 批准号:
6665374 - 财政年份:2002
- 资助金额:
$ 26.65万 - 项目类别:
Effects of nonsteroidal antiinflammatory agents on thyroid hormone levels
非甾体抗炎药对甲状腺激素水平的影响
- 批准号:
6465857 - 财政年份:2000
- 资助金额:
$ 26.65万 - 项目类别:
ROLE OF NONSTEROIDAL ANTIINFLAMMATORY AGENTS IN OUTCOME OF OA
非甾体类抗炎药在 OA 结局中的作用
- 批准号:
6318272 - 财政年份:2000
- 资助金额:
$ 26.65万 - 项目类别:
CARIBBEAN CORALS (PSEUDOPTEROGORIA) AS SOURCE OF NEW ANTIINFLAMMATORY AGENTS)
加勒比珊瑚(PSEUDOPTEROGORIA)作为新型抗炎剂的来源)
- 批准号:
6219061 - 财政年份:1999
- 资助金额:
$ 26.65万 - 项目类别:
ROLE OF NONSTEROIDAL ANTIINFLAMMATORY AGENTS IN OUTCOME OF OA
非甾体类抗炎药在 OA 结局中的作用
- 批准号:
6100638 - 财政年份:1999
- 资助金额:
$ 26.65万 - 项目类别:
CARIBBEAN CORALS (PSEUDOPTEROGORIA) AS SOURCE OF NEW ANTIINFLAMMATORY AGENTS)
加勒比珊瑚(PSEUDOPTEROGORIA)作为新型抗炎剂的来源)
- 批准号:
6107139 - 财政年份:1998
- 资助金额:
$ 26.65万 - 项目类别: